220 related articles for article (PubMed ID: 20050195)
1. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
[TBL] [Abstract][Full Text] [Related]
2. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
[TBL] [Abstract][Full Text] [Related]
3. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
4. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
5. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Ballerini C; Aldinucci A; Luccarini I; Galante A; Manuelli C; Blandina P; Katebe M; Chazot PL; Masini E; Passani MB
Br J Pharmacol; 2013 Sep; 170(1):67-77. PubMed ID: 23735232
[TBL] [Abstract][Full Text] [Related]
7. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
[TBL] [Abstract][Full Text] [Related]
8. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
[TBL] [Abstract][Full Text] [Related]
10. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
11. The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
Tsutahara K; Okumi M; Kakuta Y; Abe T; Yazawa K; Miyagawa S; Matsunami K; Otsuka H; Kaimori J; Takahara S; Nonomura N
Nephrol Dial Transplant; 2012 Oct; 27(10):3799-806. PubMed ID: 22904101
[TBL] [Abstract][Full Text] [Related]
12. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
13. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.
Gao P; Zhou XY; Yashiro-Ohtani Y; Yang YF; Sugimoto N; Ono S; Nakanishi T; Obika S; Imanishi T; Egawa T; Nagasawa T; Fujiwara H; Hamaoka T
J Leukoc Biol; 2003 Feb; 73(2):273-80. PubMed ID: 12554804
[TBL] [Abstract][Full Text] [Related]
14. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
[TBL] [Abstract][Full Text] [Related]
15. CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.
Nedjai B; Viney JM; Li H; Hull C; Anderson CA; Horie T; Horuk R; Vaidehi N; Pease JE
Br J Pharmacol; 2015 Apr; 172(7):1822-33. PubMed ID: 25425280
[TBL] [Abstract][Full Text] [Related]
16. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
17. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease.
Sporici R; Issekutz TB
Eur J Immunol; 2010 Oct; 40(10):2751-61. PubMed ID: 21038468
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.
O'Connor RA; Li X; Blumerman S; Anderton SM; Noelle RJ; Dalton DK
J Immunol; 2012 Mar; 188(5):2093-101. PubMed ID: 22287719
[TBL] [Abstract][Full Text] [Related]
20. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
